Cash & equivalents decreased 31.0%
Cash & equivalents changed -31.0% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -31.0% from the comparable as-filed period.
Inventory changed -22.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Net income changed -129.8% from the comparable as-filed period.
Operating income changed -65.7% from the comparable as-filed period.
Operating margin changed -5307 basis points from the comparable as-filed period.
Research & development changed +68.0% from the comparable as-filed period.
Selling, general & administrative changed +11.2% from the comparable as-filed period.
Revenue changed -3.9% from the comparable as-filed period.
Stock-based compensation changed +0.0% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.